Psychiatr. pro Praxi, 2008; 9(4): 174-176

Stimulants in child AND ADOLESCENT OUTPATIENT CARE

doc. MUDr. Libuše Stárková CSc
Soukromá psychiatrická ambulance, Olomouc

Stimulants represent medicaments of the first choice for the treatment of ADHD in children and adolescents. The caution associated with their prescription has in our country intelligible historical and medical causes. The target of this article is to disperse doubts about this therapy and to encourage psychiatrists to use methylphenidate in ADHD treatment.

Keywords: Key words: ADHD, stimulans, targets, apprehensions, benefit.

Published: November 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Stárková L. Stimulants in child AND ADOLESCENT OUTPATIENT CARE. Psychiatr. praxi. 2008;9(4):174-176.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Abikoff H et al. Sequential pharmacotherapy for children with comorbid attention - deficit/hyperaktivity and anxiety disorders. J Am Acad Child Adolesc Psychiatry, 2005, 44(5): 418-427. Go to original source... Go to PubMed...
    2. Biederman J et al. Stimulants therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study. Am J Psychiatry, 2008, 165(5): 597-603. Go to original source... Go to PubMed...
    3. Hanc T, Cieslik J. Growth in stimulant - naive children with attention - deficit/hyperaktivity disorder using cross-sectional and longitudinal approaches. Pediatrics, 2008, 121(4): 967-974. Go to original source... Go to PubMed...
    4. Hort V, Hrdlička M, Kocourková J, Malá E. Dětská a adolescentní psychiatrie. Praha: Portál 2000.
    5. Hrdlička M. Postavení atomoxetinu v léčbě hyperkinetické poruchy u dětí a adolescentů. Čs. Psychiat, 2007, 103: 230-239.
    6. Charach A et al. Using stimulant medication for children with ADHD: What do parents say? A Brief Report. J Can Acad Child Adolesc Psychiatry 2008, 15(2): 75-83.
    7. Medřická H, Kunčíková M, Novák. ADHD. Neurol. pro praxi, 2007, 4(8): 219-221.
    8. Munden A, Arcelus J. Poruchy pozornosti a hyperaktivita. Praha: Portál 2002.
    9. Paclt I. Současnost a perspektivy psychofarmakoterapie ADHD v České republice a v zahraničí. Psychiatr. pro Praxi 2006, 1(7): 34-37.
    10. Preen DR et al. Prescribing of psychostimulant medications for attention deficit hyperaktivity disorder in children: differences between clinical speciallities. Med J Aust, 2008, 188(6): 337-339. Go to original source... Go to PubMed...
    11. Sadock JB, Sadock VA. Kaplan and Sadock´s synopsis of psychiatry. Behavioral Sciences/ Clinical psychiatry. 9th edition. Philadelphia: Lippincott Wiliams and Wilkins, 2003.
    12. Sears J, Patel NC. Development of tics in a thirteen-year-old male following atomoxetine use. CNS Spectr., 2008, 13(4): 301-303. Go to original source... Go to PubMed...
    13. Solhkhah R et al. Bupropion SR for the treatment of substance-abusing outpatient adolescents with attention - deficit/hyperaktivity disorder and mood disorders. J Child Adolesc Psychopharmacol, 2005, 15(5): 777-786. Go to original source... Go to PubMed...
    14. Stein MA. Innovations in attention - deficit/hyperaktivity disorders pharmacotherapy: long - acting stimulant and nonstimulant treatments. Am J Manag Care, 2004, 10: 589-598.
    15. Wigal SB, Wilens TE, Wolraich M, Lerner M. Hematologic and blood biochemistry monitoring during methylphenidate treatment in children with attention - deficit/hyperaktivity disorder: 2-year, open-label study results. Pediatrics 2007, 120(1):120-128. Go to original source... Go to PubMed...
    16. Wilens TE, Prince JB, Spenser TJ, Biederman J. Stimulants and sudden death: What is a physician to do? Pediatrics, 2006, 118(3): 1215-1219. Go to original source... Go to PubMed...
    17. Wilens TE. The nature of the relationship between attention - deficity/hyperaktivity disorder and substance use. J Clin Psychiatry, 2007, 68(Suppl. 11): 4-8. Go to original source...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.